Monica Plöen has a BSc in Pharmacy, graduating from Uppsala University, Sweden in 1991.

She joined the UMC in 1992, initially working with the entry of individual case safety reports (ICSR) into Vigibase, providing support to National Centres (NC), coding new drugs in the Drug Dictionary, and making searches in the database on request. 

Monica has also been involved in projects using denominator data, sales information, together with the data in Vigibase, as part of signal analysis process.

Monica currently manages the teams who work with the content in the databases ? Vigibase, WHO Drug Dictionary Enhanced, Traditional medicines, WHO-ART.

Since 1999 she has been an observer in the WHO working group on ATC and DDD classifications.

Languages: Swedish, English 

E-mail: monica.ploen@who-umc.org

Publications
Lindquist M, Pettersson M, Edwards IR, et al. Omeprazole and Visual Disorders: Seeing alternatives. Pharmacoepidemiology and Drug Safety 1996; 5:27-32.

Lindquist M, Pettersson M, Edwards IR, et al. How does cystitis affect a comparative risk profile of tiaprofenic acid with other non-steroidal anti-inflammatory drugs? An international study based on spontaneous reports and drug usage data. ADR Signals Analysis Project (ASAP) Team. Pharmacol Toxicol 1997; 80(5):211-7.

Ståhl M, Lindquist M, Pettersson M, et al. Withdrawal reactions with selective serotonin re-uptake inhibitors as reported to the WHO system. Eur J Clin Pharmacol 1997; 53(3-4):163-9.

Edwards IR, Fletcher AP, Lindquist M, Pettersson M, Sanderson GH, Schou JS. The ADR Signal Analysis (ASAP) - Final Report. EU funded technical report 1997.

De Bruin ML, Pettersson M, Meyboom RH, Hoes AW, Leufkens HG. Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death. Eur Heart J 2005; 26(6):590-7.

Posters
Pettersson M, Lindquist M, Edwards IR. Signal analysis using international ADR and drug utilization data. 8th Annual Meeting European Society of Pharmacovigilance 2000, Verona, Italy: 76.

Lindquist M, Pettersson M, Edwards IR. Can fexofenadine cause heart rhythm disorders? Pharmacoepidemiology and Drug Safety 2003;12(Supplement S1-S189):184, abstract # 365.

Meyboom RHB, Pettersson M, Kiuru A. Selective Serotonin Reuptake Inhibitors (SSRIs), Hypertension and Hypotension. Pharmacoepidemiology and Drug Safety, 2003, 12, Suppl: S246.

Star K, Ståhl M, Strandell J, Pettersson M, Lindquist M. Abstracts of the 2004 ISoP annual conference: WHO signals from 1998 to 2001 - a follow-up. Drug Safety 2004; 27(12):961-962.

Meyboom RH, Kiuru A, Strandell J, Pettersson M, Edwards IR. Abstracts of the 2004 ISoP annual conference: Reports of leukaemia and lymphoma during the use of clozapine and other atypical neuroleptics. Drug Safety 2004; 27(12):948.